Peritoneal Carcinomatosis Extent Evaluation: Radiologic, Laparoscopic and Pathologic.
Imaging Evaluation of Peritoneal Carcinomatosis Extent
1 other identifier
observational
80
1 country
1
Brief Summary
pathologically proved ovarian cancer patients that underwent contrast enhanced abdomino-pelvic CT and diagnostic laparoscopy before cytoreductive surgery (CRS) will be included in the study. Calculation of PCI (peritoneal cancer index) using Sugarbaker's method, peritoneal carcinomatosis extent will be categorized into low, moderate and large. Agreement in general and in each category between CT, laparoscopy, surgery and pathology will be assessed using kappa agreement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
January 7, 2019
CompletedFirst Posted
Study publicly available on registry
January 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 11, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedJanuary 9, 2019
January 1, 2019
5 months
January 7, 2019
January 7, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
peritoneal carcinomatosis
Agreement in general and in each category between CT, laparoscopy, surgery and pathology was assessed using kappa agreement.
one year
Secondary Outcomes (1)
surgical decision making.
one year
Interventions
evaluation of peritoneal carcinomatosis by laparoscopy
Eligibility Criteria
pathologically proved ovarian cancer patients recived cytoreductive surgery and underwent preoperative CT and diagnostic laparoscopy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
South Egypt Cancer Institute
Asyut, 11517, Egypt
Related Publications (1)
Fagotti A, Ferrandina G, Fanfani F, Garganese G, Vizzielli G, Carone V, Salerno MG, Scambia G. Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. Am J Obstet Gynecol. 2008 Dec;199(6):642.e1-6. doi: 10.1016/j.ajog.2008.06.052. Epub 2008 Sep 17.
PMID: 18801470BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- lecturer of radiodiagnosis
Study Record Dates
First Submitted
January 7, 2019
First Posted
January 9, 2019
Study Start
January 1, 2019
Primary Completion
June 11, 2019
Study Completion
December 1, 2020
Last Updated
January 9, 2019
Record last verified: 2019-01